Incidence and Risk Factors of Radiation-Induced Lung Injury

Overall Incidence Rates

• Approximately 45-49% of lung cancer patients treated with radiotherapy develop respiratory symptoms, though about 45% of these symptoms are not related to radiation but rather to other conditions 1, 3
• Less than 5% frequency of grade 3 acute pulmonary toxicities in all recent chemoradiotherapy trials 1, 3, 4
• 10-15% of patients may still develop severe radiation-induced toxicity even when doses previously considered safe are used 2

Treatment-Specific Incidence

• Grade 3-4 toxicity was not significantly increased when adding immunotherapy after chemoradiotherapy in the PACIFIC trial 1, 3, 4
• The addition of immunotherapy has been associated with an increase in pulmonary toxicities of any grade, though severe toxicity rates remain low 1, 3, 4

Critical Risk Factors That Modify Incidence

• Patients with pre-existing interstitial lung disease have a markedly elevated risk of severe and even lethal radiation pneumonitis, requiring more intensive counseling and monitoring 1, 3, 2
• V20 of 35-37% or mean lung dose of 20-23 Gy are considered upper safety limits, yet 10-15% of patients still develop severe toxicity below these thresholds 2

Temporal Pattern

• Acute radiation pneumonitis occurs during or 2-6 months after radiotherapy 1, 3, 4, 7
• Radiation-induced pulmonary fibrosis typically develops 6-12 months following completion of radiotherapy 1, 3, 4